EXHIBIT 31.2

I, Daniel Sullivan, certify that:

     1.   I have reviewed this quarterly report on Form 10-QSB of Stem Cell
Therapy International, Inc.

     2.   Based on my knowledge,  this report does not contain any untrue
statement  of a  material  fact  or  omit to  state  a  material  fact necessary
to make the statements  made, in light of circumstances under which such
statements were made, not misleading with respect to the period covered by this
report;

     3.   Based on my knowledge, the condensed consolidated financial
statements, and other financial information  included in this report,  fairly
present in all material respects the consolidated financial condition,
consolidated results of operations and consolidated cash flows of the small
business issuer as of, and for, the periods presented in this report;

     4.   The small business issuer's  other certifying  officers and I are
responsible for establishing  and maintaining  disclosure  controls and
procedures (as defined in Exchange  Act Rules  13a-15(e) and 15d-15(e)) and
internal controls over financial reporting (as defined in Exchange Act Rules 13a
- 15(f) and 15d - 15(f)) for the small business issuer and have:

          a)   designed such  disclosure  controls and procedures, or caused
such disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the small business issuer, included
its consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this report is being prepared;

          b)   designed such internal control over financial reporting, or
caused such internal control over financial reporting to be designed under our
supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles.

          c)   evaluated the effectiveness of the small business issuer's
disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end
of the period covered by this report based on such evaluation;

          d)   disclosed in this report any change in the small business
issuer's internal control over financial reporting that occurred during the
small business issuer's most recent fiscal quarter that has materially affected,
or is reasonably likely to materially affect, the small business issuer's
internal control over financial reporting; and

     5.   The small business issuer's other certifying officers and I have
disclosed, based on our most recent  evaluation of internal control over
financial reporting,  to the small business issuer's  auditors and the audit
committee  of  small business issuer's  board  of  directors  (or  persons
performing the equivalent functions):

          a)   all  significant  deficiencies and material weaknesses in the
design  or  operation  of internal control over financial reporting which are
reasonably likely to affect the small business issuer's ability to record,
process,  summarize and report financial information; and

          b)   any fraud, whether or not material, that involves management or
other employees who have a significant role in the small business issuer's
internal control over financial reporting.



/s/ Daniel Sullivan                                    August 14, 2007
-------------------                                    ---------------
Daniel Sullivan
Chief Financial Officer and Chief Accounting Officer